Neupogen G-CSF data

Two separate studies of Neupogen published in The New England Journal of Medicine produced mixed results on the clinical utility of the drug in certain settings (see Noteworthy, BioCentury Part I).

Mayo Clinic researchers (Rochester, Minn.) and colleagues published a randomized, double-blind, placebo-controlled trial

Read the full 440 word article

How to gain access

Continue reading with a
two-week free trial.